Cancer News and Research

Latest Cancer News and Research

GE Healthcare becomes US distributor and reseller of Veran's ig4 navigation system

GE Healthcare and Veran, a provider of proprietary 4D registration capability for precise targeting of lesions via its FDA cleared platform, today announced a strategic supplier agreement in which GE Healthcare becomes the exclusive distributor and reseller of Veran's ig4 navigation system in the United States.

18 Jan 2011

Harbor Biosciences signs development agreements for HE2000, HE3235 and HE3286 with CIPI

Harbor BioSciences, Inc., a leader in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals, announced it has licensed the research and development and commercialization rights for three of its products, exclusively in the People's Republic of China and Hong Kong, to China State Institute of Pharmaceutical Industry (CIPI).

18 Jan 2011

New data on role of miR-34 tumor suppressor in preventing cancer stem cell development

Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today the publication of new data in the journal Nature Medicine describing the role of the tumor suppressor miRNA, miR-34, in preventing cancer stem cell development. The published results reveal that miR-34 is commonly down-regulated in prostate cancer stem cells and that this down-regulation is essential for cancer stem cell viability.

18 Jan 2011

NCI sponsors fourth REOLYSIN clinical trial in pancreatic cancer

Oncolytics Biotech Inc. announced today that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN® versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.

18 Jan 2011

Heart failure patients admitted to general wards twice as likely to die

Heart failure patients admitted to general wards are twice as likely to die as those admitted to cardiology wards, shows a national audit of the treatment of the condition, published online in the journal Heart.

18 Jan 2011

Quebec reimburses VIDAZA for treatment of blood cancer

Quebec patients with serious blood cancers (intermediate-2 and high-risk myelodysplastic syndrome and acute myeloid leukemia) now have publicly funded access to a new innovative therapy, VIDAZA® (azacitidine). Following a priority review and subsequent positive recommendation from the Conseil du medicament, patients now have the potential to significantly extend survival.

18 Jan 2011

Hamilton Academy of Medicine launches campaign to increase awareness about smoking cessation

In honour of National Non-Smoking Week, The Hamilton Academy of Medicine is proud to introduce, It's Hamilton's Time to Quit, a campaign designed to increase awareness about local quitting resources and tools to help the community understand the support that is available, and encourage people to seek the assistance they need to stop smoking.

18 Jan 2011

Time constraints, patient embarrassment prevent full-body skin cancer examinations

Time constraints, other illnesses and patient embarrassment may prevent dermatologists, internists and family practitioners from conducting full-body skin examinations, according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals. However, dermatologists are significantly more likely than internists and family practitioners to conduct such screenings.

18 Jan 2011

American Heart Association honors SBUMC with Get With The Guidelines-Stroke Gold Plus Performance Achievement Award

Stony Brook University Medical Center has received the 2009 American Heart Association/American Stroke Association's Get With The Guidelines Stroke Gold Plus Performance Achievement Award.

18 Jan 2011

Women's Health Congress to explore mammography controversy

The ongoing controversy about the appropriate age, frequency, and patient benefit of mammography will be explored at the upcoming 19th Annual Congress on Women's Health, April 1-3, 2011 in Washington DC.

18 Jan 2011

Follow-up program for high-risk patients appears to detect melanomas at early stages

A follow-up program for patients at high risk of developing skin cancer appears to be associated with the detection of melanomas at early stages and with good prognosis, according to a report posted online today that will appear in the May print issue of Archives of Dermatology, one of the JAMA/Archives journals.

18 Jan 2011

Bathing tumor-ridden livers in chemotherapy increases survival time

Bathing tumor-ridden livers in chemotherapy increases the length of time certain cancer patients survive without progression of the disease, according to Phase III trial results being presented at the 3rd annual Symposium on Clinical Interventional Oncology (CIO), in collaboration with the International Symposium on Endovascular Therapy (ISET).

18 Jan 2011

Vaccine to prevent MRSA infections after bone and joint surgery

University of Rochester Medical Center orthopaedic scientists are a step closer to developing a vaccine to prevent life-threatening methicillin-resistant staphylococcus aureus (MRSA) infections following bone and joint surgery.

18 Jan 2011

New way to halt lung inflammation

Acute inflammation of the lung is a poorly recognized human disease that develops in surprising and unexpected ways. The acute lung injury (ALI) or adult respiratory distress syndrome (ARDS) is a vital new concern for soldiers, but it can develop in anyone during a systemic infection, after severe trauma, as a result of bone fracture, following severe burns and in many other ways as well-- the initial cause may have nothing apparent to do with the lung itself.

18 Jan 2011

PecFent accepted in Scotland for treatment of breakthrough cancer pain

Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.

18 Jan 2011

OMJPI, Sanford-Burnham enter agreement to discover compounds for Alzheimer's disease, psychiatric disorders

Sanford-Burnham Medical Research Institute has entered into a collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc., to discover compounds for Alzheimer's disease and major psychiatric disorders.

18 Jan 2011

T3SS-dependent bacteria may be a suitable point of attack for future antibiotics: Study

So-called type-3 secretion systems of pathogenic bacteria may be a suitable point of attack for future antibiotics. This is shown by Professor Maria Fällman and her associates at Umeå University in Sweden in the Proceeding of the National Academy of Sciences, PNAS, in the US.

18 Jan 2011

Regeneron, Bayer and SERI initiate new VEGF Trap-Eye Phase 3 clinical trial in myopic CNV

Regeneron and Bayer HealthCare announced initiation of a new Phase 3 clinical trial in collaboration with the Singapore Eye Research Institute investigating the efficacy and safety of VEGF Trap-Eye (aflibercept ophthalmic solution) in patients with choroidal neovascularisation (CNV) of the retina as a result of pathologic myopia.

18 Jan 2011

Scientists identify new way of attacking breast cancer stem cells

Scientists at the University of Michigan Comprehensive Cancer Center have identified a potential new way of attacking breast cancer stem cells, the small number of cells in a tumor that fuel its growth and spread.

18 Jan 2011

Cincinnati Children's provides tips on how to stop the spread of flu germs

Doctors at Cincinnati Children's Hospital Medical Center want to make sure children are protected from influenza this flu season. The flu is an infection of the nose, throat and lungs caused by a variety of strains of influenza viruses.

18 Jan 2011

Cancer News and Research

Latest Cancer News and Research

GE Healthcare becomes US distributor and reseller of Veran's ig4 navigation system

Harbor Biosciences signs development agreements for HE2000, HE3235 and HE3286 with CIPI

New data on role of miR-34 tumor suppressor in preventing cancer stem cell development

NCI sponsors fourth REOLYSIN clinical trial in pancreatic cancer

Heart failure patients admitted to general wards twice as likely to die

Quebec reimburses VIDAZA for treatment of blood cancer

Hamilton Academy of Medicine launches campaign to increase awareness about smoking cessation

Time constraints, patient embarrassment prevent full-body skin cancer examinations

American Heart Association honors SBUMC with Get With The Guidelines-Stroke Gold Plus Performance Achievement Award

Women's Health Congress to explore mammography controversy

Follow-up program for high-risk patients appears to detect melanomas at early stages

Bathing tumor-ridden livers in chemotherapy increases survival time

Vaccine to prevent MRSA infections after bone and joint surgery

New way to halt lung inflammation

PecFent accepted in Scotland for treatment of breakthrough cancer pain

OMJPI, Sanford-Burnham enter agreement to discover compounds for Alzheimer's disease, psychiatric disorders

T3SS-dependent bacteria may be a suitable point of attack for future antibiotics: Study

Regeneron, Bayer and SERI initiate new VEGF Trap-Eye Phase 3 clinical trial in myopic CNV

Scientists identify new way of attacking breast cancer stem cells

Cincinnati Children's provides tips on how to stop the spread of flu germs

Industry Focus eBook - Oncology (1st Edition) eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in